- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956704
The Different Design of Orthokeratology
July 14, 2023 updated by: Tianjin Eye Hospital
The Effectiveness and Safety of Different Design of Orthokeratology Lenses to Reduce Myopia Growth
In this study, we intend to enroll orthokeratology subjects aged 8-18 years old with binocular myopia up to and including -4.00 D. They were randomly selected to wear both orthokeratology of different designs, one with an aspheric wide inversion zone design in the optical zone and the other with a traditional spherical curved segment design, and to investigate the differences between these two lenses in terms of their effectiveness in myopia retardation, defocus, and aberration.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tianjin, China, 300020
- Tianjin Eye Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- The age is greater than 8 years and less than 18 years
- The myopia was within -4.00D (including -4.00D), and the astigmatism was within 1.50D (including 1.50D) in both eyes.
- Be able to complete 12 months of follow-up
- They were able to understand the purpose of the trial, volunteered to participate, and signed informed consent by the subjects themselves or their legal guardians
Exclusion Criteria:
- One eye met the inclusion criteria
- Patients with systemic diseases causing immunocompromised or affecting orthokeratology
- There are other eye diseases that affect orthokeratology lens wearing, such as dacryocystitis, blepharitis, various inflammation, glaucoma, etc
- Abnormal cornea
- Previous corneal surgery or corneal trauma history
- Active keratitis (e.g., corneal infection)
- Patients with best corrected distance visual acuity of less than 5.0
- Patients with corneal flat curvature lower than 39.00D, or higher than 48.00D
- Patients with refractive instability
- Patients with overt strabismus
- The corneal epithelium showed obvious fluorescent staining, which was not suitable for patients wearing orthokeratology lenses
- Patients with dry eye are not suitable for orthokeratology
- Patients with corneal endothelial cell density less than 2000 cells /mm2
- Patients who had worn rigid contact lenses (including orthokeratology lenses) within the previous 30 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
|
An orthokeratology lens with an altered optical zone design is designed for an aspherical wide inversion arc in the optical zone
|
Active Comparator: Control group
|
Subjects wore the orthokeratology with traditional spherical design in the optical zone
|
No Intervention: Blank control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in axial length
Time Frame: The change of baseline and 1years
|
Axial length was measured with a biometer
|
The change of baseline and 1years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2020
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
July 14, 2023
First Submitted That Met QC Criteria
July 14, 2023
First Posted (Actual)
July 21, 2023
Study Record Updates
Last Update Posted (Actual)
July 21, 2023
Last Update Submitted That Met QC Criteria
July 14, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY2023031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterRecruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Universidad Complutense de MadridCooperativa de Ensino Superior, Politécnico e Universitário; Novovision; Instituto... and other collaboratorsActive, not recruiting
-
Nova Southeastern UniversityWithdrawnMyopia, Progressive
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling by invitationHigh Myopia | Pathologic MyopiaChina
-
National Taiwan University HospitalUnknown
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting